Skip to main content
SHENZHEN LIFOTRONIC TECHNOLOGY CO.,LTD logo

SHENZHEN LIFOTRONIC TECHNOLOGY CO.,LTD — Investor Relations & Filings

Ticker · 688389 ISIN · CNE100005WZ5 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 812 across all filing types
Latest filing 2026-01-19 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688389

About SHENZHEN LIFOTRONIC TECHNOLOGY CO.,LTD

https://en.lifotronic.com/

SHENZHEN LIFOTRONIC TECHNOLOGY CO.,LTD. specializes in the research, development, and manufacturing of medical equipment for therapeutic and diagnostic applications. The company’s therapeutic portfolio includes negative pressure wound therapy (NPWT) systems, high-frequency chest wall oscillation devices for airway clearance, and various physical therapy and rehabilitation solutions. In the field of in-vitro diagnostics, it offers high-performance liquid chromatography (HPLC) hemoglobin analyzers for diabetes management and chemiluminescence immunoassay (CLIA) platforms. Lifotronic integrates advanced engineering with clinical requirements to provide solutions for wound care, respiratory health, and laboratory testing. The company serves a global market, focusing on technological innovation and the delivery of precise, reliable medical instruments designed to improve patient outcomes across diverse clinical settings.

Recent filings

Filing Released Lang Actions
深圳普门科技股份有限公司关于自愿披露取得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure announcement by Shenzhen Pumen Technology Co., Ltd. regarding the receipt of a medical device registration certificate issued by the Guangdong Provincial Drug Administration. It details the product name, registration classification, certificate number, validity period, and intended use. The document also discusses the impact of this registration on the company and includes a risk warning about the uncertainty of future sales impact. The document is short (1049 characters) and serves as an official announcement of a regulatory approval rather than a financial report or detailed management discussion. It does not contain financial data, earnings information, or management changes. Therefore, it fits best into the category of Regulatory Filings (RNS), which is a fallback for miscellaneous regulatory announcements that do not fit other specific categories.
2026-01-19 Chinese
深圳普门科技股份有限公司关于股票期权激励计划2025年第四季度自主行权结果的公告
Transaction in Own Shares Classification · 95% confidence The document is a detailed announcement regarding the stock option incentive plans for the fourth quarter of 2025 by Shenzhen Pumen Technology Co., Ltd. It includes information about the stock option exercise results, the decision-making process, the number of shares involved, and the impact on financial reports. The document is an official announcement of the stock option exercise results and related corporate governance actions, not a full financial report or earnings release. It is not a proxy solicitation, nor a remuneration report, nor a management discussion. It is a formal disclosure of stock option exercise outcomes and related board decisions, which fits the category of Transaction in Own Shares (POS), as it relates to the company's stock option exercises and share issuance or cancellation. The document is lengthy and detailed, not a brief announcement or a report publication notice, so it is not RPA or RNS. Therefore, the best classification is POS (Transaction in Own Shares).
2026-01-05 Chinese
深圳普门科技股份有限公司关于自愿披露取得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure announcement by Shenzhen Pumen Technology Co., Ltd. about obtaining a medical device registration certificate issued by the National Medical Products Administration of China. It details the product registration certificate number, validity, and intended use, and discusses the impact on the company and risk warnings. The document is short (1079 characters) and serves as an official announcement of a regulatory approval event rather than a financial report or detailed management discussion. It does not contain financial data, earnings, or management changes. It is not a report but an announcement of a regulatory milestone relevant to investors. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-01-05 Chinese
深圳普门科技股份有限公司关于自愿披露取得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure announcement by Shenzhen Pumen Technology Co., Ltd. regarding the receipt of a medical device registration certificate issued by the Guangdong Provincial Drug Administration. It details the product name, registration classification, certificate number, validity period, and intended use. The document also discusses the impact of this registration on the company and includes a risk warning about the uncertainty of future sales impact. The document is short (1067 characters) and serves as an official announcement of a regulatory approval rather than a financial report or detailed management discussion. It does not contain financial data, earnings information, or management changes. Therefore, it fits best into the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other specific categories.
2025-12-26 Chinese
深圳普门科技股份有限公司关于非独立董事离任暨选举职工代表董事的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of a non-independent director and the election of a new employee representative director. It details changes in the board composition, including dates of resignation and election, reasons for the changes, and compliance with relevant laws and company bylaws. There are no financial statements, earnings data, or detailed financial analysis present. The document is focused on board/management changes rather than financial reporting or other regulatory filings. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication but a direct announcement of management changes.
2025-12-23 Chinese
北京市中伦（深圳）律师事务所关于深圳普门科技股份有限公司2025年第一次临时股东大会的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the convening, procedures, qualifications of attendees, and voting results of the 2025 first extraordinary general meeting (临时股东大会) of Shenzhen Pumen Technology Co., Ltd. It details the legality and compliance of the meeting process, the qualifications of attendees, and the validity of the voting results. This is not the actual shareholder meeting materials or voting results announcement but a legal opinion on the meeting's conduct. The document is not an Annual Report, Earnings Release, or any financial report. It is also not a Proxy Solicitation or Voting Results announcement. The document is a legal opinion related to the shareholder meeting, which fits best under Regulatory Filings (RNS) as it does not fit other specific categories and is a compliance/legal document related to corporate governance and shareholder meetings.
2025-12-16 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.